Limba
|
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1)with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.
Price | 16.249,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1)with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD. |